Michael A Eufemio Jr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 422 Normal Street, Suite B, East Stroudsburg, PA 18301 Phone: 570-424-2100 Fax: 570-421-7407 |
James E Moyer, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 422 Normal Street, East Stroudsburg, PA 18301 Phone: 570-424-2100 Fax: 570-421-7407 |
Thomas Howard Gulick, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 175 E Brown St, Suite 204, East Stroudsburg, PA 18301 Phone: 570-424-7390 Fax: 570-424-7395 |
Dr. Scott Ira Rosen, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2031 Hay Terrace, Easton, PA 18042 Phone: 610-252-8291 Fax: 610-252-7577 |
Donald R Mcnellis, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 3729 Easton Nazareth Hwy, Suite 201, Easton, PA 18045 Phone: 610-253-6999 Fax: 610-253-7808 |
Dr. Joseph Wolfgang Aquilina, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 76 Saddle Ln, Easton, PA 18045 Phone: 610-515-8656 |
Paul J Sisbarro, DO Urology Medicare: Not Enrolled in Medicare Practice Location: 175 Martin Ave Ste 350, Ephrata, PA 17522 Phone: 717-738-5632 Fax: 717-738-6535 |
Lori Mae Dulabon, DO Urology Medicare: Accepting Medicare Assignments Practice Location: 5401 Peach St Ste 3600, Erie, PA 16509 Phone: 814-868-2170 Fax: 814-868-2108 |
Dr. Ankur Malpani, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 311 W 24th St Ste 101, Erie, PA 16502 Phone: 814-452-4214 Fax: 814-459-7823 |
Dr. Thomas Francis Walsh, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 100 Peach St Ste 102, Erie, PA 16507 Phone: 814-877-5700 Fax: 814-877-5655 |
Justine Schober, Urology Medicare: Accepting Medicare Assignments Practice Location: 300 State St Ste 301b, Erie, PA 16507 Phone: 814-877-5700 |
Dr. Daniel T Wendel, D.O. Urology Medicare: Not Enrolled in Medicare Practice Location: 5473 Village Common Dr, Suite 201, Erie, PA 16506 Phone: 814-833-3223 Fax: 814-833-5763 |
Michael Miller, Urology Medicare: Accepting Medicare Assignments Practice Location: 100 Peach St Ste 102, Suite 102, Erie, PA 16507 Phone: 814-877-5700 |
Zdzislaw J Chorazy, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 311 West 24th Street, Suite 101, Erie, PA 16502 Phone: 814-452-4214 Fax: 814-461-8424 |
Peter S Lund, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 311 W 24th St Ste 101, Erie, PA 16502 Phone: 814-452-4214 Fax: 814-459-7823 |
Rene Pedro Molina, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 300 State Street, Lakeview Urologic Surgeons, Ste 302, Erie, PA 16507 Phone: 814-877-5700 Fax: 814-877-5655 |
Burkhardt H Zorn, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 311 W 24th St Ste 101, Erie, PA 16502 Phone: 814-452-4214 Fax: 814-459-7823 |
David A Dulabon, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 300 State St, Suite 301h, Erie, PA 16507 Phone: 814-877-5700 Fax: 814-877-5655 |
Peter J Bridges, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 100 Peach St, Suite 102, Erie, PA 16507 Phone: 814-877-5700 Fax: 814-877-5655 |
Michael Richard Evankovich, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 311 W 24th St, Suite 101, Erie, PA 16502 Phone: 814-452-4214 Fax: 814-459-7823 |
News Archive
The Ensign Group, Inc., the parent company of the Ensign™ group of skilled nursing, rehabilitative care services and assisted living companies, today announced that its Board of Directors has declared a quarterly cash dividend of $0.055 per share of Ensign common stock, payable on or before January 31, 2011 to shareholders of record as of December 31, 2010.
Prolonged exposure therapy is more effective at treating PTSD than Seeking Safety, a coping skills therapy, for patients who also have alcohol use disorder, found a VA San Diego Healthcare System study.
Genentech, Inc. a wholly-owned member of the Roche Group, and Biogen Idec announced today that the companies received a Complete Response from the U.S. Food and Drug Administration (FDA) for a supplemental Biologics License Application (sBLA) for Rituxan (rituximab) plus methotrexate (MTX) in patients with moderately-to-severely active rheumatoid arthritis (RA) who no longer respond to treatment with a disease modifying antirheumatic drug (DMARD), including MTX.
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today it received a Notice of Allowance from the United States Patent and Trademark Office covering technology relating to monoclonal antibodies that bind to certain epitopes present on pancreatic cancers. This patent will broaden the Company's proprietary intellectual property for ICT-109 and ICT-37, two of the Company's monoclonal antibody product candidates.
› Verified 7 days ago